Fungal infections, caused by various fungi, can affect different parts of the body and present a spectrum of illnesses ranging from mild to severe. Common types include superficial infections like ringworm and athlete's foot, as well as more serious systemic infections that can impact internal organs. Risk factors for fungal infections include weakened immune systems, certain medical treatments, and environmental exposures. Candida species are common culprits, causing infections such as thrush and vaginal yeast infections. Aspergillus and Cryptococcus can lead to serious respiratory infections, particularly in immunocompromised individuals. Diagnosis involves clinical assessment and laboratory testing, with treatment varying based on the type and severity of the infection. Antifungal medications, both topical and systemic, are commonly prescribed. However, resistance to antifungal drugs is a growing concern. Preventive measures include maintaining good hygiene, avoiding prolonged exposure to damp environments, and addressing underlying health conditions. Fungal infections highlight the importance of both proper diagnosis and timely, targeted treatment to ensure favorable outcomes. Ongoing research aims to improve diagnostic methods, treatment options, and our understanding of the complex interactions between fungi and the human immune system.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States